Ebrahim NAA, Eissa TS, Hussein MA, Arafat A, Amin NH. Toward Precision Oncology in Ovarian Cancer: Dual PD-L1 and CD44 Biomarker Profiling for Recurrence Risk Assessment. Asian Pac J Cancer Biol [Internet]. 2025 Aug. 23 [cited 2026 Jun. 4];10(3):689-98. Available from: http://waocp.com/journal/index.php/apjcb/article/view/1942